| Direct Competitor Comparison | |
|---|
| AGEN | ABPI | DNDN | OPTR | Industry |
|---|
| Market Cap: | 113.50M | 1.53M | 602.83M | 703.03M | 71.76B |
|---|
| Employees: | 53 | 51 | 1,050 | 281 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | -0.92 | -0.56 | -0.18 | 0.35 | 0.27 |
|---|
| Revenue (ttm):
| 3.70M | 3.37M | 311.05M | 106.58M | 13.93B |
|---|
| Gross Margin (ttm): | 0.75 | 0.18 | 0.32 | 0.88 | 0.72 |
|---|
| EBITDA (ttm): | -17.93M | -11.90M | -223.63M | -86.79M | 1.51B |
|---|
| Operating Margin (ttm):
| -5.18 | -3.58 | -0.84 | -0.82 | 0.13 |
|---|
| Net Income (ttm): | -27.53M | -12.77M | -361.70M | -57.40M | N/A |
|---|
| EPS (ttm): | -1.13 | -0.15 | -2.42 | -1.21 | 0.61 |
|---|
| P/E (ttm): | N/A | N/A | N/A | N/A | 18.43 |
|---|
| PEG (5 yr expected): | N/A | N/A | -0.03 | -0.38 | 1.51 |
|---|
| P/S (ttm): | 31.71 | 0.45 | 1.93 | 6.72 | 3.64 |
|---|
|
| ABPI = Accentia Biopharmaceuticals, Inc. | | DNDN = Dendreon Corp. | | OPTR = Optimer Pharmaceuticals, Inc. | | Industry = Biotechnology | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 104.24 | 0.02 | 78.18B | 17.64 |
|---|
| Genentech, Inc. | Private |
|---|
| Biogen Idec Inc. | BIIB | 231.33 | 0.03 | 54.91B | 36.71 |
|---|
| Genzyme Corporation | Private |
|---|
| Merck Serono S.A. | Private |
|---|
| Gilead Sciences Inc. | GILD | 56.47 | 0.01 | 86.14B | 31.62 |
|---|
| MedImmune, L.L.C. | Private |
|---|
| Life Technologies Corporation | LIFE | 73.68 | 0.00 | 12.68B | 31.19 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.21 | 0.00 | 34.26B | 20.07 |
|---|
| Sandoz International GmbH | Private |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 130.20 | 0.02 | 16.63B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private |
|---|
| Mylan, Inc. | MYL | 31.23 | -0.00 | 11.90B | 20.86 |
|---|
| Pfizer Inc. | PFE | 28.78 | 0.00 | 204.14B | 13.78 |
|---|
| Johnson & Johnson | JNJ | 88.59 | 0.01 | 248.84B | 24.06 |
|---|
| GlaxoSmithKline plc | GSK | 52.65 | 0.01 | 127.52B | 19.24 |
|---|
| Sanofi | SNY | 55.05 | 0.02 | 145.70B | 27.13 |
|---|
| Novartis AG | NVS | 74.63 | 0.01 | 183.38B | 18.94 |
|---|
| Roche Holding AG | RHHBY | 64.71 | 0.02 | 219.62B | 21.66 |
|---|
| AstraZeneca PLC | AZN | 51.71 | 0.00 | 64.64B | 11.44 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.72 | -0.00 | 58.80B | 11.50 |
|---|
| Bristol-Myers Squibb Company | BMY | 44.06 | 0.01 | 72.37B | 49.90 |
|---|
|
| News on Direct Competitors | |
|---|
- OPTR
- Nasdaq stocks posting largest percentage increases AP Tue 8:50pm
- OPTR
- OPTIMER PHARMACEUTICALS INC Financials EDGAR Online Financials Fri, May 17
- DNDN
- Bayer's Xofigo Cleared in the US Zacks Thu, May 16
- DNDN
- One Person's Trash Is Another Person's Treasure Portfolio at Motley Fool Thu, May 16
- OPTR
- Cubist bid for Optimer before sale process began-sources at Reuters Wed, May 15
- OPTR
- Cubist bid almost $1 billion for Optimer before sale process: sources at Reuters Wed, May 15
- OPTR
- Cubist bid almost $1 bln for Optimer before sale process-sources at Reuters Wed, May 15
- DNDN
- DENDREON CORP Financials EDGAR Online Financials Wed, May 15
- DNDN
- Analysis - A hard day to be a short-seller, one of many this year at Reuters Thu, May 9
- DNDN
- Dendreon says competition hurt 1Q Provenge sales AP Thu, May 9
- ABPI
- NIH tops the list of Biovest creditors at bizjournals.com Fri, Mar 8
- ABPI
- ACCENTIA BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events EDGAR Online Thu, Mar 7
- ABPI
- Biovest Files Recapitalization Plan to Strengthen Balance Sheet and Advance Commercialization Strategy for BiovaxID™ Cancer Vaccine Business Wire Thu, Mar 7
- ABPI
- ACCENTIA BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online Fri, Feb 22
- ABPI
- ACCENTIA BIOPHARMACEUTICALS INC Financials EDGAR Online Financials Thu, Feb 21
All Headlines for these symbols... Currency in USD. | |
|
0.45%